P-51 Short- and Long-Term Outcomes of Infliximab Treatment for Refractory Ulcerative Colitis and Rel...
P-51 Short- and Long-Term Outcomes of Infliximab Treatment for Refractory Ulcerative Colitis and Related Prognostic Factors: A Japanese Single-Center Study
About this item
Full title
Author / Creator
Publisher
Oxford, UK: Oxford University Press
Journal title
Language
English
Formats
Publication information
Publisher
Oxford, UK: Oxford University Press
Subjects
More information
Scope and Contents
Contents
In Japan, infliximab (IFX) has been established as a useful treatment option for patients diagnosed with refractory ulcerative colitis (UC). However, the details of IFX treatment in Japanese patients with refractory UC remain unclear. We analyzed the short- and long-term outcomes of IFX treatment in Japanese patients with refractory UC and related...
Alternative Titles
Full title
P-51 Short- and Long-Term Outcomes of Infliximab Treatment for Refractory Ulcerative Colitis and Related Prognostic Factors: A Japanese Single-Center Study
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_3169786941
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_3169786941
Other Identifiers
ISSN
1078-0998
E-ISSN
1536-4844
DOI
10.1097/00054725-201212001-00084
